These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 7512578)

  • 1. Delayed-type hypersensitivity response in experimental autoimmune neuritis treated with peptide-coupled spleen cells.
    Gregorian SK; Rostami A
    J Neuroimmunol; 1994 Apr; 51(1):69-75. PubMed ID: 7512578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of experimental autoimmune neuritis by transforming growth factor-beta 1.
    Gregorian SK; Lee WP; Beck LS; Rostami A; Amento EP
    Cell Immunol; 1994 Jun; 156(1):102-12. PubMed ID: 7515330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of peripheral tolerance with peptide-specific anergy in experimental autoimmune neuritis.
    Gregorian SK; Clark L; Heber-Katz E; Amento EP; Rostami A
    Cell Immunol; 1993 Sep; 150(2):298-310. PubMed ID: 7690307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of experimental autoimmune neuritis by nasal administration of P2 protein peptide 57-81.
    Zhu J; Deng GM; Levi M; Wahren B; Diab A; van der Meide PH; Link H
    J Neuropathol Exp Neurol; 1998 Mar; 57(3):291-301. PubMed ID: 9600221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peptide 53-78 of myelin P2 protein is a T cell epitope for the induction of experimental autoimmune neuritis.
    Rostami A; Gregorian SK
    Cell Immunol; 1991 Feb; 132(2):433-41. PubMed ID: 1703049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic effect of transforming growth factor-beta 2 on actively induced EAN but not adoptive transfer EAN.
    Jung S; Schluesener HJ; Schmidt B; Fontana A; Toyka KV; Hartung HP
    Immunology; 1994 Dec; 83(4):545-51. PubMed ID: 7533133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of experimental autoimmune neuritis in Lewis rats by oral application of myelin antigens.
    Gaupp S; Hartung HP; Toyka K; Jung S
    J Neuroimmunol; 1997 Nov; 79(2):129-37. PubMed ID: 9394785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of severe experimental autoimmune neuritis with a synthetic peptide corresponding to the 53-78 amino acid sequence of the myelin P2 protein.
    Rostami A; Gregorian SK; Brown MJ; Pleasure DE
    J Neuroimmunol; 1990 Dec; 30(2-3):145-51. PubMed ID: 1699975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resistance and susceptibility to experimental autoimmune neuritis in Sprague-Dawley and Lewis rats correlate with different levels of autoreactive T and B cell responses to myelin antigens.
    Zhu J; Zou LP; Bakhiet M; Mix E
    J Neurosci Res; 1998 Nov; 54(3):373-81. PubMed ID: 9819142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular mRNA expression of interferon-gamma, IL-4 and transforming growth factor-beta (TGF-beta) by rat mononuclear cells stimulated with peripheral nerve myelin antigens in experimental allergic neuritis.
    Zhu J; Mix E; Olsson T; Link H
    Clin Exp Immunol; 1994 Nov; 98(2):306-12. PubMed ID: 7955537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral tolerance in experimental autoimmune neuritis (EAN) of the Lewis rat. II. Adjuvant effects and bystander suppression in P2 peptide-induced EAN.
    Jung S; Gaupp S; Hartung HP; Toyka KV
    J Neuroimmunol; 2001 May; 116(1):21-8. PubMed ID: 11311326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of experimental autoimmune neuritis by an antibody to the lymphocyte function-associated antigen-1.
    Archelos JJ; Mäurer M; Jung S; Miyasaka M; Tamatani T; Toyka KV; Hartung HP
    Lab Invest; 1994 May; 70(5):667-75. PubMed ID: 8196363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nasal administration of multiple antigens suppresses experimental autoimmune myasthenia gravis, encephalomyelitis and neuritis.
    Shi FD; Bai XF; Xiao BG; van der Meide PH; Link H
    J Neurol Sci; 1998 Feb; 155(1):1-12. PubMed ID: 9562316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention and therapy of experimental autoimmune neuritis by an antibody against T cell receptors-alpha/beta.
    Jung S; Krämer S; Schluesener HJ; Hünig T; Toyka K; Hartung HP
    J Immunol; 1992 Jun; 148(12):3768-75. PubMed ID: 1376340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment with P2 protein peptide 57-81 by nasal route is effective in Lewis rat experimental autoimmune neuritis.
    Zou LP; Zhu J; Deng GM; Levi M; Wahren B; Diab A; Hillert J; Link H
    J Neuroimmunol; 1998 May; 85(2):137-45. PubMed ID: 9630162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccination, prevention, and treatment of experimental autoimmune neuritis (EAN) by an oligomerized T cell epitope.
    Stienekemeier M; Falk K; Rötzschke O; Weishaupt A; Schneider C; Toyka KV; Gold R; Strominger JL
    Proc Natl Acad Sci U S A; 2001 Nov; 98(24):13872-7. PubMed ID: 11717443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement of acute phase and inhibition of chronic phase of experimental autoimmune neuritis in Lewis rats by intranasal administration of recombinant mouse interleukin 17: potential immunoregulatory role.
    Pelidou SH; Zou LP; Deretzi G; Oniding C; Mix E; Zhu J
    Exp Neurol; 2000 May; 163(1):165-72. PubMed ID: 10785455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of experimental allergic neuritis in the BN rat: P2 protein-specific T cells overcome resistance to actively induced disease.
    Linington C; Mann A; Izumo S; Uyemura K; Suzuki M; Meyermann R; Wekerle H
    J Immunol; 1986 Dec; 137(12):3826-31. PubMed ID: 2431045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biphasic form of experimental autoimmune neuritis in dark Agouti rats and its oral therapy by antigen-specific tolerization.
    Jung S; Gaupp S; Korn T; Köllner G; Hartung HP; Toyka KV
    J Neurosci Res; 2004 Feb; 75(4):524-35. PubMed ID: 14743436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intranasal administration of recombinant mouse interleukin-12 increases inflammation and demyelination in chronic experimental autoimmune neuritis in Lewis rats.
    Pelidou SH; Zou LP; Deretzi G; Nennesmo I; Wei L; Mix E; Van Der Meide PH; Zhu J
    Scand J Immunol; 2000 Jan; 51(1):29-35. PubMed ID: 10632973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.